OncoSil Medical Limited (ASX:OSL)

Revenue by Product

Financials in millions AUD. Fiscal year is July - June.

Year Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2011	Jun 30, 2010	Jun 30, 2009	Jun 30, 2008
Device Development for New Medical Treatments	516.63K
Device Development for New Medical Treatments Growth	40.51%

Revenue by Geography

Financials in millions AUD. Fiscal year is July - June.

Year Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2011	Jun 30, 2010	Jun 30, 2009	Jun 30, 2008
Europe	456.63K
Europe Growth	308.48%
Australia and New Zealand	60.00K
Australia and New Zealand Growth	-76.55%